Whitehawk Therapeutics (WHWK) Total Current Liabilities (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Total Current Liabilities of $11.1 million for Q1 2026, down 9.92% year-over-year from $12.3 million in Q1 2025, and down 23.85% quarter-over-quarter from $14.5 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Total Current Liabilities (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Total Current Liabilities for 17 consecutive years, with $11.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 9.92% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $11.1 million (down 9.92% YoY), while the FY2025 annual figure was $14.5 million, down 14.96% from the prior year.
- Total Current Liabilities retreated to $11.1 million in Q1 2026 per WHWK's latest filing, from $14.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $26.4 million in Q4 2023 and bottomed at $8.8 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $15.9 million across 5 years, with a median of $15.8 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 470.45% — and 2025, when it plunged 60.46%.
- Whitehawk Therapeutics' Total Current Liabilities stood at $18.8 million in 2022, then surged by 40.14% to $26.4 million in 2023, then plunged by 35.31% to $17.1 million in 2024, then slipped by 14.96% to $14.5 million in 2025, then decreased by 23.85% to $11.1 million in 2026.
- Business Quant data shows WHWK's Total Current Liabilities at $11.1 million in Q1 2026, $14.5 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 11.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.07 Mn |
| Mar 31, 2026 | 11.06 Mn |
| Dec 31, 2025 | 14.52 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | 12.27 Mn |
| Dec 31, 2024 | 17.07 Mn |
| Sep 30, 2024 | 15.81 Mn |
| Jun 30, 2024 | 22.15 Mn |
| Mar 31, 2024 | 19.88 Mn |
| Dec 31, 2023 | 26.40 Mn |
| Sep 30, 2023 | 20.52 Mn |
| Jun 30, 2023 | 13.00 Mn |
| Mar 31, 2023 | 17.75 Mn |
| Dec 31, 2022 | 18.84 Mn |
| Sep 30, 2022 | 17.89 Mn |
| Jun 30, 2022 | 12.60 Mn |
| Mar 31, 2022 | 11.51 Mn |
| Dec 31, 2021 | 15.27 Mn |
| Sep 30, 2021 | 11.57 Mn |